The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 09, 2024

Filed:

Feb. 08, 2019
Applicant:

Genentech, Inc., South San Francisco, CA (US);

Inventors:

Diego Ellerman, San Francisco, CA (US);

Teemu T. Junttila, San Mateo, CA (US);

Twyla Noelle Lombana, San Francisco, CA (US);

Dionysos Slaga, Richmond, CA (US);

Christoph Spiess, Mountain View, CA (US);

Assignee:

Genentech, Inc., South San Francisco, CA (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61P 35/00 (2006.01); C07K 16/32 (2006.01); A61K 39/395 (2006.01); A61K 47/65 (2017.01); A61K 9/00 (2006.01); C07K 16/46 (2006.01); C07K 16/10 (2006.01); A61P 35/02 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2809 (2013.01); A61K 9/0019 (2013.01); A61K 39/3955 (2013.01); A61K 47/65 (2017.08); A61P 35/00 (2018.01); A61P 35/02 (2018.01); C07K 16/1063 (2013.01); C07K 16/2803 (2013.01); C07K 16/2818 (2013.01); C07K 16/32 (2013.01); C07K 16/468 (2013.01);
Abstract

The present invention provides bispecific antigen-binding molecules having a monovalent arm specific to a first target antigen (e.g., a T cell antigen, such as CD3) and a bivalent arm specific for a second target antigen (e.g., a tumor antigen, such as HER2). Bispecific antigen-binding molecules are useful in the treatment of disorders, such as cancer (e.g., HER2-positive cancer). The invention also features methods of producing bispecific antigen-binding molecules, methods of treating disorders using bispecific antigen-binding molecules, and compositions including bispecific antigen-binding molecules.


Find Patent Forward Citations

Loading…